Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment)
Abstract Background Management of metastatic melanoma is changing rapidly following the introduction of innovative effective therapies, with consequences for the allocation of healthcare resources. The objective of this study was to assess hospitalisation costs of metastatic melanoma in France from...
Saved in:
Main Authors: | Jérôme Fernandes (Author), Bruno Bregman (Author), Patrick Combemale (Author), Camille Amaz (Author), Lucie de Léotoing (Author), Alexandre Vainchtock (Author), Anne-Françoise Gaudin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
by: Bruno Bregman, et al.
Published: (2020) -
Palabras de Luis Santos Spitale
by: Luis Santos Spitale
Published: (2014) -
Evaluating cost benefits of combination therapies for advanced melanoma
by: Ivar S Jensen, et al.
Published: (2016) -
Spital als Lebensform, Band 2 Österreichische Spitalordnungen und Spitalinstruktionen der Neuzeit
by: Scheutz, Martin
Published: (2015) -
Spital als Lebensform, Band 1 Österreichische Spitalordnungen und Spitalinstruktionen der Neuzeit
by: Scheutz, Martin
Published: (2015)